Who owns Xenon Pharmaceuticals? XENE Stock Ownership

Xenon (XENE) Ownership Overview

0.09% Other Institutional Investors

7.53% ETFs

64.06% Public Companies and

Individual Investors

The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 35.81% of the company’s stock is owned by Institutional Investors, 0.13% is owned by Insiders, and 64.06% is owned by Public Companies and Individual Investors.

The ownership structure of Xenon (XENE) stock is a mix of institutional, retail, and individual investors. Approximately 28.28% of the company’s stock is owned by Institutional Investors, 0.13% is owned by Insiders, and 7.53% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$261189622
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$8740061
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$513581
Mar 31, 2024	Deerfield Management Company, Lp	xxxxxxxxxxxxx	$93952722

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	4,740,028	Institution	4.90%	323,554,311
Richard Driehaus	4,491,653	Institution	4.65%	306,600,234
	3,501,794	Institution	3.62%	239,032,458
	2,676,154	Institution	2.77%	182,674,272
	2,120,384	Institution	2.19%	144,737,412
	1,855,964	Institution	1.92%	126,688,103
James E. Flynn	1,615,696	Institution	1.67%	110,287,409
	1,262,485	Institution	1.31%	86,177,226
	1,056,630	Institution	1.09%	72,125,564
	1,056,458	Institution	1.09%	72,113,823

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
3,501,794	Institution	3.62%	239,032,458
2,676,154	Institution	2.77%	182,674,272
2,120,384	Institution	2.19%	144,737,412
1,855,964	Institution	1.92%	126,688,103
1,262,485	Institution	1.31%	86,177,226
1,056,630	Institution	1.09%	72,125,564
1,056,458	Institution	1.09%	72,113,823
961,000	Institution	0.99%	65,597,860
920,237	Institution	0.95%	62,815,378
888,033	Institution	0.92%	60,617,133

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,545,570	Institution	2.63%	173,760,608
iShares Russell 2000 Growth ETF	901,405	Institution	0.93%	61,529,905
iShares Biotechnology ETF	665,805	Institution	0.69%	45,447,849
Vanguard Russell 2000 ETF	564,724	Institution	0.58%	34,086,741
T. Rowe Price Capital Appreciation Equity ETF	323,800	Institution	0.33%	21,688,124
-	172,692	Institution	0.18%	11,566,910
Fidelity Enhanced Small Cap ETF	149,980	Institution	0.16%	10,045,660
SPDR Portfolio Developed World ex-US ETF	149,012	Institution	0.15%	9,980,824
Vanguard Russell 2000 Growth ETF	104,976	Institution	0.11%	6,336,351
ALPS Medical Breakthroughs ETF	104,962	Institution	0.11%	7,164,706

FAQ

Who Owns Xenon Pharmaceuticals (XENE)?

According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 0.13% is held by insiders, and 64.06% is held by retail investors.

What percentage of Xenon Pharmaceuticals (XENE) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.09% of Xenon Pharmaceuticals (XENE) stock is held by institutional investors.

What percentage of Xenon Pharmaceuticals (XENE) stock is held by retail investors?

According to the latest TipRanks data, approximately 64.06% of Xenon Pharmaceuticals (XENE) stock is held by retail investors.

Who owns the most shares of Xenon Pharmaceuticals (XENE)?

iShares owns the most shares of Xenon Pharmaceuticals (XENE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Xenon (XENE) Ownership - Who Owns Xenon?